pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
about
Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance?Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg databaseAntiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource SettingsCell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patientsPhylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.HIV-1 drug resistance mutations: an updated framework for the second decade of HAARTComplex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy.Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2.A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.Antiretroviral drug resistance in human immunodeficiency virus type 2.Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture.Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.High level of HIV-2 false positivity in KwaZulu-Natal province: a region of South Africa with a very high HIV-1 subtype C prevalence.High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen.Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
P2860
Q25256872-B4C037E8-66A2-4639-887F-E96C04B04679Q33321434-B94D520E-B15A-4A13-90D9-9F86714B6A13Q34730950-E51D80ED-4BFB-4BE0-975C-B386A184F271Q34742090-7C4258AF-4495-4EB0-959D-76F7439FC908Q36525347-3C776C54-EF8E-4DC3-9310-4F8FFB307546Q36900010-966AC8FE-5620-4731-9E1F-E2A02BF20225Q37026564-1247D974-B2FC-474E-A7B9-CA645EFC989EQ37072022-B02D3D87-26D4-4167-8F9A-62EEA412A957Q37083896-50398D1B-3E57-4940-8516-354B440F75A1Q37256366-69DA62CF-C339-418D-805E-DE29CE68014FQ37432131-957D3BBE-0FE6-4BEE-B801-04F5C771D7CCQ37496287-19370CA2-AF95-414A-9575-9E1B9E86F310Q37859395-F6B21212-4C83-4861-ADCC-36903364EA81Q38755690-62256025-4F5F-4F55-9A7E-5FA197289437Q38935015-74DE8C58-1327-4EFD-83CC-7B68D41F045CQ41761525-F1C5275A-9D16-43FA-8E48-A215E5FFCF1FQ42275624-68977C79-DD1C-4864-9265-D152B55344D1Q45032977-2A9400E9-813C-4C63-974D-5220C236FD74Q47560712-7A455288-F918-4B5A-80EE-8A72F2E7AD2F
P2860
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
@en
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
@nl
type
label
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
@en
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
@nl
prefLabel
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
@en
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
@nl
P2093
P1476
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
@en
P2093
Anders Blaxhult
Björn Tuvesson
Christina Broström
Eleonor Brandin
Jan Albert
Katarina Gyllensten
Lars Hagberg
Lena Lindborg
Magnus Gisslen
P304
P356
10.1089/088922203322230905
P577
2003-07-01T00:00:00Z